ORONSKY ARNOLD L

CIK 000120783322 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001207833

Recent Transactions

50 trades

Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (right to buy)
2020-10-01+7,000→ 7,000 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series A Preferred Stock
2020-09-29−3,488,398→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series C Preferred Stock
2020-09-29−265,203→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series Seed Preferred Stock
2020-09-29−1,620,101→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series Seed Preferred Stock
2020-09-29−1,620,101→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,040,654→ 6,204,153 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series C Preferred Stock
2020-09-29−265,203→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+3,488,398→ 5,164,054 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series A Preferred Stock
2020-09-29−3,488,398→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series B Preferred Stock
2020-09-29−1,040,654→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+265,203→ 6,469,356 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,620,101→ 1,675,656 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Series B Preferred Stock
2020-09-29−1,040,654→ 0 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+3,488,398→ 5,163,499 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,040,654→ 6,204,708 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+1,620,101→ 1,675,101 total
Conversion
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-29+265,203→ 6,469,911 total
Purchase
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-25$18.00/sh+55,000→ 55,000 total
Purchase
PMV Pharmaceuticals, Inc.$PMVP
Common Stock
2020-09-25$18.00/sh+55,555→ 55,555 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2020-05-28+25,000→ 25,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2019-10-02+7,000→ 7,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2019-05-30+15,000→ 15,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2018-10-03+7,000→ 7,000 total
Purchase
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2018-09-10$17.00/sh+58,824→ 388,766 total
Exercise/Conversion
TESARO, Inc.
Common Stock
2018-08-07+10,000→ 12,479 total
Exercise/Conversion
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2018-08-07−10,000→ 0 total
Sale
TESARO, Inc.
Common Stock
2018-08-07$26.77/sh−10,000→ 2,479 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2018-05-31+15,000→ 15,000 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2017-09-27+6,000→ 6,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2017-06-02+7,500→ 7,500 total
Award
TESARO, Inc.
Common Stock
2017-06-01+335→ 1,338 total
Award
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2017-06-01+12,000→ 12,000 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Common
2017-04-24+28→ 11,208 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Warrant to buy Common
2017-04-24−328→ 0 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Warrant to buy Common
2017-04-24−11,476→ 0 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Warrant to buy Common
2017-04-24−91→ 0 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Common
2017-04-24+3,559→ 1,404,515 total
Exercise of In-Money
APPLIED GENETIC TECHNOLOGIES CORP
Common
2017-04-24+101→ 40,181 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Director Stock Option (Right to Buy)
2017-03-23+12,000→ 12,000 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2017-02-28+8,000→ 8,000 total
Award
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2016-06-01+12,000→ 12,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2016-05-31+7,500→ 7,500 total
Purchase
TESARO, Inc.
Common Stock
2016-03-18$35.19/sh+142,085→ 2,013,786 total
Award
APPLIED GENETIC TECHNOLOGIES CORP
Stock Option (right to buy)
2015-11-19+6,200→ 6,200 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2015-10-13+13,200→ 13,200 total
Award
TESARO, Inc.
Common Stock
2015-06-01+1,003→ 10,096 total
Award
TESARO, Inc.
Director Nonqualified Stock Option (right to buy)
2015-06-01+10,000→ 10,000 total
Award
DYNAVAX TECHNOLOGIES CORP$DVAX
Option (Right to Buy)
2015-05-27+7,500→ 7,500 total
Other
TESARO, Inc.
Common Stock
2015-01-12+1,263→ 9,093 total
Other
TESARO, Inc.
Common Stock
2015-01-12−600,000→ 1,871,701 total

Recent Filings

Address

11119 NORTH TORREY PINES ROAD

LA JOLLA, CA, 92037

View on SEC.gov